Cytotoxicity and oxidative stress in human liver carcinoma cells exposed to arsenic trioxide (HepG(2))
- PMID: 20657712
- PMCID: PMC2908498
Cytotoxicity and oxidative stress in human liver carcinoma cells exposed to arsenic trioxide (HepG(2))
Abstract
Arsenic is a trace element that occurs naturally in the earth's crust. It has been found to be a major contaminant in groundwater supply in several countries of the world. Whether ingested or inhaled, arsenic induces both systemic (skin disorders, cardiovascular diseases, anemia, peripheral neuropathy, liver and kidney damage) and carcinogenic (skin, lung, bladder and liver neoplasms) effects. However, its molecular mechanisms of toxicity are not completely understood. In this research, we used HepG(2) cells as a model to study the cytotoxicity and oxidative stress associated with exposure to arsenic trioxide. We hypothesized that oxidative stress plays a role in arsenic trioxide induced cytotoxicity. To test this hypothesis, we performed both MTT [3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide] assay and trypan blue exclusion test for cell viability and the thiobarbituric acid test for lipid peroxidation. Data obtained from the MTT assay indicated that arsenic trioxide significantly reduced the viability of HepG(2) cells, showing a LD(50) value of about 23 mug/mL upon 24 h of exposure, indicating a dose-dependent response. Similar trend was obtained with the trypan blue exclusion test. Data generated from the thiobarbituric acid test showed a significant increase (p </= 0.05) in MDA levels in arsenic trioxide-treated HepG(2) cells compared to control cells. Arsenic trioxide treatment significantly increased cellular content of reactive oxygen species (ROS), as evidenced by the increase in lipid peroxidation by-products. Taken together, these results indicate that arsenic trioxide is cytotoxic to HepG(2) cells. This cytotoxicity is mediated by oxidative stress, a biomarker of cellular injury.
Figures




Similar articles
-
OXIDATIVE STRESS IN HUMAN LEUKEMIA (HL-60), HUMAN LIVER CARCINOMA (HepG2), AND HUMAN (JURKAT-T) CELLS EXPOSED TO ARSENIC TRIOXIDE.Met Ions Biol Med. 2006;9:298-303. Met Ions Biol Med. 2006. PMID: 26435679 Free PMC article.
-
N-acetyl-l-cysteine affords protection against lead-induced cytotoxicity and oxidative stress in human liver carcinoma (HepG2) cells.Int J Environ Res Public Health. 2007 Jun;4(2):132-7. doi: 10.3390/ijerph2007040007. Int J Environ Res Public Health. 2007. PMID: 17617676 Free PMC article.
-
Cytotoxic Effect of Arsenic Trioxide in Adenocarcinoma Colorectal Cancer (HT-29) Cells.Met Ions Biol Med. 2008 Jan 1;10:458-462. Met Ions Biol Med. 2008. PMID: 21603592 Free PMC article.
-
Arsenic trioxide-mediated oxidative stress and genotoxicity in human hepatocellular carcinoma cells.Onco Targets Ther. 2013;6:75-84. doi: 10.2147/OTT.S38227. Epub 2013 Feb 7. Onco Targets Ther. 2013. PMID: 23404534 Free PMC article.
-
Involvement of oxidative stress in methyl parathion and parathion-induced toxicity and genotoxicity to human liver carcinoma (HepG₂) cells.Environ Toxicol. 2013 Jun;28(6):342-8. doi: 10.1002/tox.20725. Epub 2011 May 4. Environ Toxicol. 2013. PMID: 21544925 Free PMC article.
Cited by
-
Heavy metal toxicity and the environment.Exp Suppl. 2012;101:133-64. doi: 10.1007/978-3-7643-8340-4_6. Exp Suppl. 2012. PMID: 22945569 Free PMC article. Review.
-
Factors determining sensitivity and resistance of tumor cells to arsenic trioxide.PLoS One. 2012;7(5):e35584. doi: 10.1371/journal.pone.0035584. Epub 2012 May 10. PLoS One. 2012. PMID: 22590507 Free PMC article.
-
Identification of Potential Antiviral Inhibitors from Hydroxychloroquine and 1,2,4,5-Tetraoxanes Analogues and Investigation of the Mechanism of Action in SARS-CoV-2.Int J Mol Sci. 2022 Feb 4;23(3):1781. doi: 10.3390/ijms23031781. Int J Mol Sci. 2022. PMID: 35163703 Free PMC article.
-
"Double-edged sword" effect of reactive oxygen species (ROS) in tumor development and carcinogenesis.Physiol Res. 2023 Jul 14;72(3):301-307. doi: 10.33549/physiolres.935007. Physiol Res. 2023. PMID: 37449744 Free PMC article. Review.
-
Combined arsenic trioxide-cisplatin treatment enhances apoptosis in oral squamous cell carcinoma cells.Cell Oncol (Dordr). 2014 Apr;37(2):119-29. doi: 10.1007/s13402-014-0167-7. Epub 2014 Mar 6. Cell Oncol (Dordr). 2014. PMID: 24599717
References
-
- ATSDR. Toxicological Profile for Arsenic (Update) Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service; 1998.
-
- Kenyon E, Hughes M. A concise review of the toxicity and carcinogenicity of dimethylarsinic acid. Toxicology. 2001;160:227–236. - PubMed
-
- Kalia K, Flora JS. Strategies for safe andeffective therapeutic measures for chronic arsenic and lead poisoning. J Occ Health. 2005;47:1–21. - PubMed
-
- Lynn S, Gurr JR, Lai HT. NADH oxidase activation is involved in arsenite induced oxidative DNA damage in human vascular smooth muscle cells. Circ Res. 2000;86(5):514–519. - PubMed
-
- Bernstam L, Nriagu J. Molecular aspects of arsenic stress. J Toxicol Environ Health B Crit Rev. 2000;3:293–322. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials